Preparation, characterization, and pharmacokinetics of rivaroxaban cocrystals with enhanced in vitro and in vivo properties in beagle dogs

Rivaroxaban (RIV) is a direct Factor Xa inhibitor anticoagulant, but the oral bioavailability of RIV is estimated to be only 60% due to its poor solubility. The aim of the present study was to improve the solubility and bioavailability of RIV. Five cocrystals—p-hydroxybenzoic acid (HBA), 2,4-dihydro...

Full description

Bibliographic Details
Main Authors: Yuanyuan Meng, Fangyun Tan, Jiaxin Yao, Yanan Cui, Yumiao Feng, Zhiping Li, Yuli Wang, Yang Yang, Wei Gong, Meiyan Yang, Xiaolong Kong, Chunsheng Gao
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:International Journal of Pharmaceutics: X
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590156722000081